Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomeBiotech

      Biotech

      HUTCHMED Announces Expanded Coverage on National Reimbursement Drug List for ELUNATE® and ORPATHYS®
      Biotech

      HUTCHMED Announces Expanded Coverage on National Reimbursement Drug List for ELUNATE® and ORPATHYS®

      November 15, 2026
      Viking Therapeutics Highlights Clinical Data from VK2735 Obesity Program at ObesityWeek® 2026
      Biotech

      Viking Therapeutics Highlights Clinical Data from VK2735 Obesity Program at ObesityWeek® 2026

      November 15, 2026
      IDEAYA Biosciences Announces Development Candidate Nomination of IDE101, a Potential First-In-Class Inhibitor Targeting CDKN2A-Deficiency in Solid Tumors
      Biotech

      IDEAYA Biosciences Announces Development Candidate Nomination of IDE101, a Potential First-In-Class Inhibitor Targeting CDKN2A-Deficiency in Solid Tumors

      November 15, 2026
      Immunic, Inc. Reports Third Quarter 2026 Financial Results and Provides Corporate Update
      Biotech

      Immunic, Inc. Reports Third Quarter 2026 Financial Results and Provides Corporate Update

      November 14, 2026
      Palatin to Report First Quarter Fiscal Year 2027 Results
      Biotech

      Palatin to Report First Quarter Fiscal Year 2027 Results

      November 13, 2026
      TuHURA Biosciences Reports Third Quarter 2026 Financial Results and Provides a Corporate Update
      Biotech

      TuHURA Biosciences Reports Third Quarter 2026 Financial Results and Provides a Corporate Update

      November 13, 2026
      MetaVia Reports Third Quarter 2026 Financial Results and Provides Corporate Update
      Biotech

      MetaVia Reports Third Quarter 2026 Financial Results and Provides Corporate Update

      November 13, 2026
      Inhibrx Reports Third Quarter 2026 Financial Results
      Biotech

      Inhibrx Reports Third Quarter 2026 Financial Results

      November 13, 2026
      Lilly breaks ground in Pennsylvania’s Lehigh Valley on a $3.5 billion site to make next-generation obesity medicines, the latest of 10 new U.S. sites since 2020
      Biotech

      Lilly breaks ground in Pennsylvania’s Lehigh Valley on a $3.5 billion site to make next-generation obesity medicines, the latest of 10 new U.S. sites since 2020

      November 13, 2026
      Kodiak Sciences Announces Recent Business Highlights and Third Quarter 2026 Financial Results
      Biotech

      Kodiak Sciences Announces Recent Business Highlights and Third Quarter 2026 Financial Results

      November 13, 2026
      « 1 2 3 4 5 6 … 175 »

       

      LATEST NEWS

      • Health Sanofi Market Potential Boosted by Amvuttra Data

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2026